Kimia Kalaye Razi signs 608 billion rial subsidized drug supply contract with Food and Drug Organization

According to a codal filing, the company under ticker Kimazi disclosed in a material tier A disclosure published Tuesday, September 15, 2026, that it signed a contract worth 608 billion rials with Iran's Food and Drug Organization to supply and deliver subsidized medicines needed by the Health Ministry's health deputy. Under the filing, the contract runs one year, with 25 percent paid upfront and the remainder settled based on delivered volumes. The company estimated the contract's gross margin at about 15 percent and said the revenue will be recognized in fiscal year 1405. The contract's effective date is listed as September 14, 2026.